Emponza Medical SPRL

Emponza Medical reported revenue of 85,725 € for the 2021 financial year (annual accounts filed with the NBB on 26 Dec 2022).

Company number (CBE) 0475.430.553
1410 Waterloo
active in Medical specialists activities (NACE 86220)
operating since 06 Aug 2001 (≈ 25 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Emponza Medical shows with a free account.

See the score
Profile
SPRL since 2001
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2021

Revenue85,725 €
Net result1,348 €
Equity159,579 €
Cash159,568 €
EBITDA19,872 €
Total assets389,801 €
The line marks its sector median: 65.0% (4535 companies).

Change 2018 → 2021: Revenue -22 % Equity +4 % Total assets +11 %

Accounts of the company itself (not consolidated).

The full file covers 7 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Emponza Medical's annual accounts

20212019201820172016
Revenue85,725 €
Net result1,348 €
Equity159,579 €
Cash159,568 €
EBITDA19,872 €
Total assets389,801 €

Filed annual accounts

  • Year ended 31 Dec 2021filed on 26 Dec 2022
  • Year ended 31 Dec 2019filed on 24 Dec 2020
  • Year ended 31 Dec 2018filed on 28 May 2020
  • Year ended 31 Dec 2017filed on 09 Jan 2019
  • Year ended 31 Dec 2016filed on 07 Nov 2018

Emponza Medical's financial analysis

Management and control of Emponza Medical

1 active director(s) in the register.

Emponza Medical's shareholders and holdings →

Emponza Medical's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0475.430.553
VAT number
No VAT activity declared to the CBE
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SPRL
Incorporated
06 Aug 2001
Registered office
1410 Waterloo
Latest accounts
2021 · filed on 26 Dec 2022
Activity
Medical specialists activities (NACE 86220)

Emponza Medical (SPRL) has been based in Waterloo since 2001, active in: medical specialists activities. For 2021, it reports revenue of 85,725 €, a net profit of 1,348 € and equity of 159,579 €.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Emponza Medical

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Emponza Medical

What is the revenue of Emponza Medical?

According to the 2021 annual accounts filed with the NBB, the revenue of Emponza Medical amounts to 85,725 €.

What is the VAT number of Emponza Medical?

According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Emponza Medical. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0475430553. Its company number (CBE) is 0475.430.553.

Where is the registered office of Emponza Medical?

According to the CBE register, the registered office of Emponza Medical is in 1410 Waterloo.

What is the equity of Emponza Medical?

At the close of the 2021 financial year, the equity of Emponza Medical amounts to 159,579 €, a solvency of 40.9% of total assets.

Who manages Emponza Medical?

The register lists 1 active mandates at Emponza Medical. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Emponza Medical

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 19 Jul 2026

No credit card, no commitment.

What each plan unlocks →